| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |